Lista de obras -

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

artículo científico publicado en 2012

A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping

artículo científico publicado en 2017

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

artículo científico publicado en 2007

A new tool to study ribavirin-induced haemolysis

artículo científico publicado en 2012

Alginate hydrogel protects encapsulated hepatic HuH-7 cells against hepatitis C virus and other viral infections

artículo científico publicado en 2014

An appropriate selection of a 3D alginate culture model for hepatic Huh-7 cell line encapsulation intended for viral studies

artículo científico publicado en 2012

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

artículo científico publicado en 2014

Analytical performance evaluation and enhancement of the ADVIA Centaur® HIV Ag/Ab Combo assay

artículo científico publicado en 2019

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

artículo científico publicado en 2020

Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication

artículo científico publicado en 2016

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.

artículo científico publicado en 2017

BK Polyomavirus Hijacks Extracellular Vesicles for En Bloc Transmission

artículo científico publicado en 2020

BK polyomavirus in the urine for follow-up of kidney transplant recipients

scientific article published in 2019

Biology of the BKPyV: An Update

artículo científico publicado en 2017

Cell culture systems for the hepatitis C virus

artículo científico publicado en 2007

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

artículo científico publicado en 2010

Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virus

artículo científico publicado en 2017

Comparative Evaluation of Three Nucleic Acid-Based Assays for BK Virus Quantification

artículo científico publicado en 2015

Comparison of Abbott Architect®, Siemens Immulite®, and Diasorin Liaison® for determination of Epstein-Barr virus serological diagnosis

artículo científico publicado en 2017

Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study

artículo científico publicado en 2005

Correction to: The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies

artículo científico publicado en 2018

Correction: Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus

scientific article published on 19 September 2019

DHEA and progesterone have a protective effect on ribavirin-induced hemolysis

artículo científico publicado en 2014

DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase

artículo científico publicado en 2017

Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.

artículo científico publicado en 2012

Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?

artículo científico publicado en 2015

Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays

scientific article published on 07 May 2020

Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity

artículo científico publicado en 2007

Enhanced anti-HCV activity of interferon alpha 17 subtype

artículo científico publicado en 2009

Epidemiology and seasonality of acute respiratory infections in hospitalized children over four consecutive years (2012-2016)

artículo científico publicado en 2018

Equal efficacy between the two types of peginterferon on HCV: A matter of relapse? ⬇️

artículo científico publicado el 16 de febrero de 2013

Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses

artículo científico publicado en 2014

Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain

scientific article published on 26 September 2018

Genetic recombination of the hepatitis C virus: clinical implications

artículo científico publicado en 2010

Hemoglobin during ribavirin-based HCV therapy is closely related to circulating levels of DHEA.

artículo científico publicado en 2016

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion

artículo científico publicado en 2015

Hepatitis C Virus Resistance to Carbohydrate-Binding Agents

artículo científico publicado en 2016

High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients

artículo científico publicado en 2017

Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses.

artículo científico

Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication

artículo científico publicado en 2010

Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2

artículo científico publicado en 2011

Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly

artículo científico publicado en 2017

Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity

artículo científico publicado en 2010

Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors

artículo científico publicado en 2014

Immunohistochemical- and PCR-based assay for the reproducible, routine detection of erythrovirus B19 in thyroid tissues

artículo científico publicado en 2015

Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits

artículo científico publicado en 2011

Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C.

artículo científico publicado en 2013

Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virus

artículo científico publicado en 2008

MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy

artículo científico

Modeling of HBV and HCV hepatitis with hepatocyte-like cells.

artículo científico

Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma Specimens

artículo científico publicado en 2003

Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination

artículo científico publicado en 2007

NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly

artículo científico publicado en 2011

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

artículo científico publicado en 2015

New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

artículo científico publicado en 2015

No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation

scientific article published on 01 April 2019

Optimizing the treatment of chronic viral hepatitis C.

scientific article published on December 2009

Patients treated with first-generation HCV protease inhibitors exhibit high ribavirin concentrations.

artículo científico publicado en 2015

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

artículo científico publicado en 2013

Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre.

artículo científico publicado en 2015

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action

artículo científico publicado en 2015

Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation

artículo científico publicado en 2005

Regulation of core expression during the hepatitis C virus life cycle

artículo científico publicado en 2014

Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy.

artículo científico publicado en 2010

Ribavirin for chronic hepatitis E virus infection

artículo científico publicado en 2014

Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy.

scientific article published on January 2010

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

scholarly article by Baptiste Demey et al published 12 October 2018 in Journal of Clinical Virology

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins

artículo científico publicado en 2007

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions

artículo científico publicado en 2010

Role of low-density lipoprotein receptor in the hepatitis C virus life cycle

artículo científico publicado en 2012

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

artículo científico publicado en 2006

Simeprevir for the treatment of hepatitis C virus infection

artículo científico publicado en 2014

Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients

artículo científico publicado en 2011

Synthesis and in vitro activity of novel N-3 acylated TSAO-T compounds against HIV-1 and HCV.

artículo científico publicado en 2011

TaqMan amplification system with an internal positive control for HCV RNA quantitation

artículo científico publicado en 2004

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

artículo científico publicado en 2007

The antimalarial ferroquine is an inhibitor of hepatitis C virus.

artículo científico publicado en 2013

The end-of-treatment ribavirin concentration predicts hepatitis C virus relapse

artículo científico publicado en 2013

The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.

artículo científico publicado en 2013

The hepatitis C virus glycan shield and evasion of the humoral immune response

artículo científico publicado en 2011

The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.

artículo científico publicado en 2015

The treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells.

artículo científico publicado en 2011

Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies

artículo científico publicado en 2006

Which therapeutic option for hepatitis C virus genotype 1?

artículo científico publicado en 2014

Lista de obras de

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

A new tool to study ribavirin-induced haemolysis

Alginate hydrogel protects encapsulated hepatic HuH-7 cells against hepatitis C virus and other viral infections

An appropriate selection of a 3D alginate culture model for hepatic Huh-7 cell line encapsulation intended for viral studies

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

Analytical performance evaluation and enhancement of the ADVIA Centaur® HIV Ag/Ab Combo assay

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.

BK Polyomavirus Hijacks Extracellular Vesicles for En Bloc Transmission

BK polyomavirus in the urine for follow-up of kidney transplant recipients

Biology of the BKPyV: An Update

Cell culture systems for the hepatitis C virus

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virus

Comparative Evaluation of Three Nucleic Acid-Based Assays for BK Virus Quantification

Comparison of Abbott Architect®, Siemens Immulite®, and Diasorin Liaison® for determination of Epstein-Barr virus serological diagnosis

Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study

Correction to: The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies

Correction: Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus

DHEA and progesterone have a protective effect on ribavirin-induced hemolysis

DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase

Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.

Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?

Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays

Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity

Enhanced anti-HCV activity of interferon alpha 17 subtype

Epidemiology and seasonality of acute respiratory infections in hospitalized children over four consecutive years (2012-2016)

Equal efficacy between the two types of peginterferon on HCV: A matter of relapse? ⬇️

Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses

Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain

Genetic recombination of the hepatitis C virus: clinical implications

Hemoglobin during ribavirin-based HCV therapy is closely related to circulating levels of DHEA.

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion

Hepatitis C Virus Resistance to Carbohydrate-Binding Agents

High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients

Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses.

Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication

Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2

Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly

Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity

Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors

Immunohistochemical- and PCR-based assay for the reproducible, routine detection of erythrovirus B19 in thyroid tissues

Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits

Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C.

Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virus

MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy

Modeling of HBV and HCV hepatitis with hepatocyte-like cells.

Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma Specimens

Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination

NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation

Optimizing the treatment of chronic viral hepatitis C.

Patients treated with first-generation HCV protease inhibitors exhibit high ribavirin concentrations.

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre.

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action

Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation

Regulation of core expression during the hepatitis C virus life cycle

Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy.

Ribavirin for chronic hepatitis E virus infection

Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy.

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions

Role of low-density lipoprotein receptor in the hepatitis C virus life cycle

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

Simeprevir for the treatment of hepatitis C virus infection

Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients

Synthesis and in vitro activity of novel N-3 acylated TSAO-T compounds against HIV-1 and HCV.

TaqMan amplification system with an internal positive control for HCV RNA quantitation

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

The antimalarial ferroquine is an inhibitor of hepatitis C virus.

The end-of-treatment ribavirin concentration predicts hepatitis C virus relapse